Medication Browser

Reduces angiotensin effect so vessels relax and aldosterone-driven sodium and water retention decreases.

Relaxes smooth muscle in the prostate, bladder neck, and blood vessels so urine flow or blood pressure can improve.

Changes cardiac electrical conduction to terminate or prevent unsafe rhythms.

Targets bacterial growth or cell structures; exact teaching depends on the antibiotic class.

Blocks parasympathetic activity, so secretions dry up, heart rate can rise, and smooth muscle spasms decrease.

Keeps acetylcholine active longer at the neuromuscular junction to improve muscle strength.

Reduces clot formation by interfering with the coagulation cascade.

Reduces nausea through different pathways, including serotonin, dopamine, histamine, muscarinic, cannabinoid, and NK1 receptor effects.

Calms abnormal neuronal firing so seizures are less likely to start or spread.

Blocks histamine effects; first-generation agents also cause sedation and anticholinergic drying.

Lowers cholesterol production or improves lipid profile to reduce long-term plaque and vascular risk.

Makes platelets less sticky so arterial clots are less likely to form.

Modulates dopamine and other neurotransmitters to reduce psychosis, agitation, or mania.

Reduces thyroid hormone production so the high-metabolism state calms down.

Interferes with viral replication; exact target and timing depend on the antiviral.

Enhances GABA, the brain's braking system, to reduce excitability.

Blocks beta stimulation so heart rate, contractility, and blood pressure can decrease.

Opens narrowed airways by relaxing bronchial smooth muscle or reducing vagal bronchoconstriction.

Relaxes vascular smooth muscle and, for selected agents, slows AV node conduction.

Turns on parasympathetic activity, so secretions and smooth muscle activity increase while heart rate may slow.

Suppresses inflammation and immune activity; systemic use affects glucose, infection risk, and adrenal response.

Moves fluid out through the kidneys; the exact electrolyte effect depends on the class.

Boosts dopamine signaling to improve bradykinesia, rigidity, and tremor.

Reduces stomach acid so irritated tissue can heal and reflux symptoms decrease.

Moves glucose from blood into cells; also shifts potassium into cells when used with dextrose for hyperkalemia.

Traps ammonia in the gut and promotes stooling so ammonia levels and confusion can improve.

Depresses neuromuscular excitability and stabilizes seizure risk in severe preeclampsia/eclampsia.

Dilates veins and coronary vessels to reduce workload and improve oxygen supply-demand balance.

Reduces prostaglandin-mediated pain and inflammation; many agents can also affect platelet function, stomach lining, and kidney blood flow.

Stimulates uterine contraction to support labor or clamp down bleeding after birth.

Competes at opioid receptors and can rapidly reverse opioid effects.

Acts like prostaglandin signaling; the newborn cardiac use keeps the ductus arteriosus open while definitive care is arranged.

Changes neurotransmitter availability to improve mood symptoms over time.

Replaces thyroid hormone to restore metabolic function.

Acyclovir renal hydration teaching is a source-highlighted target.

Adenosine requires rapid IV administration with immediate flush and ECG monitoring.

No improvement after rescue bronchodilator is a priority.

New dyspnea or cough can signal pulmonary toxicity.

Syncope or severe hypotension after dosing is priority.

Anaphylaxis beats routine antibiotic completion teaching.

No routine INR monitoring does not mean no bleeding risk.

Rash with mucosal involvement is not a minor side effect.

Tinnitus can be a salicylate toxicity clue.

Hold and question severe bradycardia or symptomatic hypotension.

Muscle pain with dark urine can indicate rhabdomyolysis.

Sepsis treatment should not be delayed once cultures are obtained per order.

Inhaled steroids prevent inflammation; they do not rescue acute bronchospasm.

Angioedema beats routine BP teaching.

Late Parkinson medication can look like sudden functional decline.

Acute pulmonary edema or worsening dyspnea is priority.

Anaphylaxis beats routine antibiotic completion teaching.

Drowsiness can still occur with cetirizine.

Fluoroquinolone tendon and QT cautions are high-yield.

Bleeding risk rises when combined with aspirin or anticoagulants.

Antitussives and respiratory suppression are an Upper Respiratory study target.

Bradycardia with hypotension or altered mental status is priority.

Airway swelling is the priority, not routine antihistamine teaching.

Acute confusion is delirium until proven otherwise.

First-dose syncope is a classic alpha-blocker safety cue.

Hallucinations, severe confusion, syncope, or chest pain are priority findings.

Renal impairment increases accumulation and bleeding risk.

GI bleeding cues outrank routine heartburn teaching.

Antihistamine sedation and anticholinergic burden are OTC source targets.

Steroid inhalers require mouth rinsing.

Rescue inhaler comes before controller inhaler during acute symptoms.

Low potassium plus digoxin raises dysrhythmia risk.

Aminoglycoside trough and toxicity are source-highlighted targets.

Breathing difficulty beats comfort symptoms.

Fever plus rigidity plus autonomic instability suggests NMS.

Protamine sulfate is the classic heparin reversal concept.

Hypokalemia is the classic thiazide safety cue.

Black stools or coffee-ground emesis after NSAID use is a priority bleeding cue.

Basal insulin can still cause hypoglycemia even without a meal-time peak.

Low glucose or no meal available is a hold-and-question cue.

Eye pain/halos after nebulizer exposure is a glaucoma cue.

PDE-5 inhibitor plus nitrate can cause life-threatening hypotension.

Wheezing after labetalol is a priority.

Chest pain or new tachydysrhythmia after thyroid replacement needs escalation.

Angioedema is an airway emergency.

Second-generation does not mean zero sedation risk.

Airway and breathing concerns override anxiety symptoms.

Pregnancy is a hard stop for ACE/ARB teaching.

Absent reflexes, respiratory depression, or very low urine output are toxicity cues.

New crackles during mannitol can mean pulmonary edema.

Fever plus sore throat on antithyroid therapy is an agranulocytosis cue.

Involuntary movements, dystonia, or mental status change after dosing is not routine nausea care.

Check pulse and BP before giving.

Hypotension after nifedipine is priority.

Breathing difficulty beats comfort symptoms.

PDE-5 inhibitor plus nitro can cause life-threatening hypotension.

Severe watery diarrhea after acid suppression can be a C. difficile cue.

Palpitations or syncope after an antiemetic may signal QT trouble.

Start antivirals early when prescribed for flu-like illness.

Stop or question oxytocin for tachysystole or nonreassuring fetal tracing per protocol.

Ataxia and nystagmus can indicate toxicity.

Falling asleep during activities is a safety cue.

Steroids reduce inflammation but can mask infection.

Respiratory depression with a sedating antiemetic is an airway priority.

Jaundice on PTU is a high-priority safety cue.

Respiratory muscle weakness is priority.

Potassium too low before IV insulin is a protocol safety cue.

Breathing difficulty beats comfort symptoms.

Dark urine with muscle symptoms is priority.

Rescue inhaler comes before controller inhaler during acute symptoms.

Eye pain or halos after patch exposure can indicate angle-closure glaucoma.

More energy may return before mood improves, so safety planning matters.

Spironolactone spares potassium, so high K is the danger.

First-dose or dose-change orthostasis can cause falls.

Rescue inhaler comes before controller inhaler during acute symptoms.

Abdominal pain plus vomiting can signal pancreatitis.

Pregnancy with an ARB is a high-priority medication safety cue.

Sepsis treatment should not be delayed once cultures are obtained per order.

Severe headache or neurologic change can signal intracranial bleeding.